Objective

To raise profile of a spin-out company with investors, clinical influencers, healthcare commissioners and potential partners and clients.

Delivering results

Our campaign was so successful – generating significant national interest and international broadcast coverage – that we were invited to support the company with a sustained PR campaign to support its growth. With our support, the company grew from 5 to 50 people and gained international exposure.

Through a creative approach to PR over 36 months we generated 37 press releases and 12 feature articles, including a review in the Journal of Precision Medicine that we researched and drafted. This resulted in coverage in over 130 publications – including the client’s Tier One targets – both in print and online.

We supported this media relations strategy through interviews with senior NHS clinicians talking about the potential of the technology and the impact of Congenica’s solution.

We also sourced patients through patient support groups and physicians that were prepared to talk about their experiences, which created human interest stories.